Page last updated: 2024-08-23

bromocriptine and nitrophenols

bromocriptine has been researched along with nitrophenols in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agid, Y; Destée, A; Durif, F; Montastruc, JL; Pollak, P1
Clarke, CE; Deane, KH; Spieker, S1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C1

Reviews

3 review(s) available for bromocriptine and nitrophenols

ArticleYear
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4

    Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone

2002
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2004, Oct-18, Issue:4

    Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Humans; Levodopa; Nitrophenols; Parkinson Disease; Pergolide; Tolcapone

2004
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5

    Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone

2005

Trials

2 trial(s) available for bromocriptine and nitrophenols

ArticleYear
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group.
    Lancet (London, England), 1997, Sep-06, Volume: 350, Issue:9079

    Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Drug Therapy, Combination; Drug Tolerance; Humans; Levodopa; Nitrophenols; Parkinson Disease; Tolcapone

1997
Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients. Tolcapone Study Group.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1

    Topics: Aged; Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Nitrophenols; Parkinson Disease; Tolcapone; Treatment Outcome

1999

Other Studies

1 other study(ies) available for bromocriptine and nitrophenols

ArticleYear
Tolcapone: new drug. In Parkinson's disease: unacceptable risk of severe hepatitis.
    Prescrire international, 2006, Volume: 15, Issue:82

    Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Clinical Trials as Topic; Cost-Benefit Analysis; Dopamine Agonists; Hepatitis; Humans; Nitrophenols; Parkinson Disease; Treatment Outcome

2006